Molecular Biology Reports

, Volume 39, Issue 7, pp 7365–7372

Novel and recurrent LDLR gene mutations in Pakistani hypercholesterolemia patients

Authors

  • Waqas Ahmed
    • Department of Biosciences, Faculty of ScienceCOMSATS Institute of Information Technology
    • Centre for Cardiovascular Genetics, Institute Cardiovascular SciencesUniversity College London
  • Muhammad Ajmal
    • Department of Biosciences, Faculty of ScienceCOMSATS Institute of Information Technology
    • Shifa College of Medicine
  • Ahmed Sadeque
    • Department of Biosciences, Faculty of ScienceCOMSATS Institute of Information Technology
  • Roslyn A. Whittall
    • Centre for Cardiovascular Genetics, Institute Cardiovascular SciencesUniversity College London
  • Sobia Rafiq
    • Centre for Molecular GeneticsUniversity of Karachi
  • Wendy Putt
    • Centre for Cardiovascular Genetics, Institute Cardiovascular SciencesUniversity College London
  • Athar Khawaja
    • Shifa International Hospital
  • Fauzia Imtiaz
    • Dow International Medical CollegeDow University of Health Sciences
  • Nuzhat Ahmed
    • Centre for Molecular GeneticsUniversity of Karachi
  • Maleeha Azam
    • Department of Biosciences, Faculty of ScienceCOMSATS Institute of Information Technology
  • Steve E. Humphries
    • Centre for Cardiovascular Genetics, Institute Cardiovascular SciencesUniversity College London
    • Department of Biosciences, Faculty of ScienceCOMSATS Institute of Information Technology
    • Shifa College of Medicine
Article

DOI: 10.1007/s11033-012-1568-1

Cite this article as:
Ahmed, W., Ajmal, M., Sadeque, A. et al. Mol Biol Rep (2012) 39: 7365. doi:10.1007/s11033-012-1568-1

Abstract

The majority of patients with the autosomal dominant disorder familial hypercholesterolemia (FH) carry novel mutations in the low density lipoprotein receptor (LDLR) that is involved in cholesterol regulation. In different populations the spectrum of mutations identified is quite different and to date there have been only a few reports of the spectrum of mutations in FH patients from Pakistan. In order to identify the causative LDLR variants the gene was sequenced in a Pakistani FH family, while high resolution melting analysis followed by sequencing was performed in a panel of 27 unrelated sporadic hypercholesterolemia patients. In the family a novel missense variant (c.1916T > G, p.(V639G)) in exon 13 of LDLR was identified in the proband. The segregation of the identified nucleotide change in the family and carrier status screening in a group of 100 healthy subjects was done using restriction fragment length polymorphism analysis. All affected members of the FH family carried the variant and none of the non-affected members nor any of the healthy subjects. In one of the sporadic cases, two sequence changes were detected in exon 9, one of these was a recurrent missense variant (c.1211C > T; p.T404I), while the other was a novel substitution mutation (c.1214 A > C; N405T). In order to define the allelic status of this double heterozygous individual, PCR amplified fragments were cloned and sequenced, which identified that both changes occurred on the same allele. In silico tools (PolyPhen and SIFT) were used to predict the effect of the variants on the protein structure, which predicted both of these variants to have deleterious effect. These findings support the view that there will be a novel spectrum of mutations causing FH in patients with hypercholesterolaemia from Pakistan.

Keywords

HypercholesterolemiaLDLRMutationPakistani

Copyright information

© Springer Science+Business Media B.V. 2012